| 1-Methyl-1H-benzotriazole CAS:13351-73-0 EC:236-401-4, 100 mg in 2 ml vial |
LK2-CRM4201-1502 |
|
| (+)-alpha-Pinene CAS:7785-70-8 EC:232-087-8, 100 mg in ml in 1 ml ampoule |
LK2-CRM4201-1503 |
|
| (R)-(+)-Limonene CAS:5989-27-5 EC:227-813-5, 100 mg in 1 ml ampoule |
LK2-CRM4201-1504 |
|
| 1-(2-Pyridyl)piperazine CAS:34803-66-2 EC:252-220-3, 100 mg in 1 ml ampoule |
LK2-CRM4201-1505 |
|
| 1,2-Benzisothiazol-3(2H)-one CAS:2634-33-5 EC:220-120-9, 100 mg in 2 ml vial |
LK2-CRM4201-1506 |
|
| 1,2-Cyclohexanedicarboxylic anhydride, predominantly cis CAS:85-42-7 EC:201-604-9, 100 mg in 2 ml vial |
LK2-CRM4201-1507 |
|
| 1,3-Bis(2-isocyanato-2-propyl)benzene CAS:2778-42-9 EC:220-474-4, 250 mg in 1 ml ampoule |
LK2-CRM4201-1508 |
|
| 1,4-Diazabicyclo2.2.2octane CAS:280-57-9 EC:205-999-9, 100 mg in 2 ml vial |
LK2-CRM4201-1509 |
|
| 1,4-Phenylenediamine CAS:106-50-3 EC:203-404-7, 100 mg in 2 ml vial |
LK2-CRM4201-1510 |
|
| 1,5-Cyclooctadiene CAS:111-78-4 l EC:203-907-1, 100 mg in 2 ml vial |
LK2-CRM4201-1511 |
|
| 1.2-Naphthoquinone CAS:524-42-5 EC:208-360-2, 100 mg in 2 ml vial |
LK2-CRM4201-1512 |
|
| 1.4-Naphthoquinone CAS:130-15-4 l EC:204-977-6, 250mg in 2 ml vial |
LK2-CRM4201-1513 |
|
| 1-Acetyl-2-thiourea CAS:591-08-2 EC:209-699-9, 100 mg in 2 ml vial1-Ethyl-2-pyrrolidone CAS:2687-91-4 EC:220-250-6, 100 mg in 1 ml ampoule |
LK2-CRM4201-1514 |
|
| 1-Ethyl-2-pyrrolidone CAS:2687-91-4 EC:220-250-6, 100 mg in 1 ml ampoule |
LK2-CRM4201-1515 |
|
| 1H-Benzotriazole CAS:95-14-7 EC:202-394-1, 100 mg in 2 ml vial |
LK2-CRM4201-1516 |
|
| 1-Hexadecene CAS:629-73-2 EC:211-105-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1517 |
|
| 1-Naphthyl acetic acid CAS:86-87-3 EC:201-705-8, 500 mg in 2 ml vial |
LK2-CRM4201-1518 |
|
| 1-Nonadecene CAS:18435-45-5 EC:242-313-7, 100 mg in 2 ml vial |
LK2-CRM4201-1519 |
|
| 1-Propanethiol CAS:107-03-9 EC:203-455-5, 0,5 ml in 1 ml ampoule |
LK2-CRM4201-1520 |
|
| 2-(2H-Benzotriazol-2-yl)-4,6-di-tert-pentylphenol CAS:25973-55-1 EC:247-384-8, 100 mg in 2 ml vial |
LK2-CRM4201-1521 |
|
| 2-(Methylthio)benzothiazole CAS:615-22-5 EC:210-417-1, 100 mg in 2 ml vial |
LK2-CRM4201-1522 |
|
| 2,2,4-Trimethyl-1,3-pentanediol Diisobutyrate CAS:6846-50-0 EC:229-934-9, 1ml in 1 ml ampoule |
LK2-CRM4201-1523 |
|
| 1,1,3,3,5,5-Hexamethyltrisiloxane CAS:1189-93-1 EC:214-716-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1524 |
|
| 2,4,6-Tribromoanisole CAS:607-99-8, 100 mg in 2 ml vial |
LK2-CRM4201-1525 |
|
| 2,4,6-Trichloroanisole CAS:87-40-1 EC:201-743-5, 100 mg in 2 ml vial |
LK2-CRM4201-1526 |
|
| 2,4,7,9-Tetramethyl-5-decyne-4,7-diol CAS:126-86-3 EC:204-809-1, 100 mg in 2 ml vial |
LK2-CRM4201-1527 |
|
| 2,4-D CAS:94-75-7 EC:202-361-1, 100 mg in 2 ml vial |
LK2-CRM4201-1528 |
|
| 2,4-Diaminoanisole Sulfate Hydrate CAS:6219-67-6 EC:228-290-6, 100 mg in 2 ml vial |
LK2-CRM4201-1529 |
|
| 2,4-Dichlorobenzyl chloride CAS:94-99-5 EC:202-381-0, 100 mg in 1 ml ampoule |
LK2-CRM4201-1530 |
|
| 2,4-Dimethylaniline CAS:95-68-1 EC:202-440-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1531 |
|
| 2-Acetamidofluorene CAS:53-96-3 EC:200-188-6, 100 mg in 2 ml vial |
LK2-CRM4201-1532 |
|
| 2-Amino-1-naphthalenesulfonic acid CAS:81-16-3 EC:201-331-5, 100 mg in 2 ml vial |
LK2-CRM4201-1533 |
|
| 2-Amino-5-chloro-p-toluenesulfonic Acid CAS:88-53-9 EC:201-839-7, 100 mg in 2 ml vial |
LK2-CRM4201-1534 |
|
| 2-Aminoanthraquinone CAS:117-79-3 EC:204-208-4, 1000 mg in 4 ml vial |
LK2-CRM4201-1535 |
|
| 2-Butyloxyethyl acetate CAS:112-07-2 EC:203-933-3, 1ml in 1 ml ampoule |
LK2-CRM4201-1536 |
|
| 2-Chloro-1,1,2-trifluoroethyl difluoromethyl ether CAS:13838-16-9 EC:237-553-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1537 |
|
| 2-Chloroethyl Chloromethyl Ether CAS:1462-33-5, 100 mg in 2 ml vial |
LK2-CRM4201-1538 |
|
| 2-Ethylhexyl acrylate CAS:103-11-7 EC:203-080-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1539 |
|
| 2-Hydroxybenzothiazole CAS:934-34-9 EC:213-281-1, 100 mg in 2 ml vial |
LK2-CRM4201-1540 |
|
| 2-Hydroxyethyl methacrylate CAS:868-77-9 EC:212-782-2, 100 mg in 1 ml ampoule |
LK2-CRM4201-1541 |
|
| 2-Hydroxypropionitrile CAS:78-97-7 EC:201-163-2, 100 mg in 2 ml vial |
LK2-CRM4201-1542 |
|
| 2-Mercaptobenzothiazole CAS:149-30-4 EC:205-736-8, 1000 mg in 2 ml vial |
LK2-CRM4201-1543 |
|
| 2-Methoxy-4-nitroaniline CAS:97-52-9 EC:202-588-6, 100 mg in 2 ml vial |
LK2-CRM4201-1544 |
|
| 2-Methyl-1,3-dioxolane CAS:497-26-7 EC:207-841-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1545 |
|
| 2-Methylbenzothiazole CAS:120-75-2 EC:204-423-3, 100 mg in 2 ml vial |
LK2-CRM4201-1546 |
|
| 2-Methylstyrene (stabilized with TBC) CAS:611-15-4 EC:210-256-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1547 |
|
| 2-Nitrofluorene CAS:607-57-8 EC:210-138-5, 100 mg in 2 ml vial |
LK2-CRM4201-1548 |
|
| 2-Octyl-4-isothiazolin-3-one CAS:26530-20-1 EC:247-761-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1549 |
|
| 2-Picoline CAS:109-06-8 EC:203-643-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1550 |
|
| 2-Propanethiol CAS:75-33-2 EC:200-861-4, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1551 |
|
| 3-(Chloromethyl) pyridine hydrochloride CAS:6959-48-4 EC:230-150-4, 100 mg in 2 ml vial |
LK2-CRM4201-1552 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1553 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1554 |
|
| 3,3′-Dimethylbenzidine CAS:119-93-7 EC:204-358-0, 100 mg in 2 ml vial |
LK2-CRM4201-1555 |
|
| 3,6-Dichloropyridazine CAS:141-30-0 EC:205-478-6, 100 mg in 2 ml vial |
LK2-CRM4201-1556 |
|
| 3-Amino-4-methoxybenzanilide CAS:120-35-4 EC:204-388-4, 100 mg in 2 ml vial |
LK2-CRM4201-1557 |
|
| 3-Amino-4-methylbenzamide CAS:19406-86-1 EC:243-039-0, 100 mg in 2 ml vial |
LK2-CRM4201-1558 |
|
| 3-Amino-9-ethylcarbazole CAS:132-32-1 EC:205-057-7, 52 mg in 1 ml ampoule |
LK2-CRM4201-1559 |
|
| 3-Anisidine CAS:536-90-3 EC:208-651-4, 250 mg in 1 ml ampoule |
LK2-CRM4201-1560 |
|
| 3-Chloropropionitrile CAS:542-76-7 EC:208-827-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1561 |
|
| 3-Diethylaminopropionitrile CAS:5351-04-2 EC:226-323-9, 100 mg in 2 ml vial |
LK2-CRM4201-1562 |
|
| 3-Ethoxy-1-propanol CAS:111-35-3 EC:203-861-2, 100 mg in 2 ml vial |
LK2-CRM4201-1563 |
|
| 3-Methylbenzothiophene CAS:1455-18-1 EC:215-934-6, 100 mg in 2 ml vial |
LK2-CRM4201-1564 |
|
| 4,4′-Bis(dimethylamino)benzophenone CAS:90-94-8 EC:202-027-5, 100 mg in 2 ml vial |
LK2-CRM4201-1565 |
|
| 4,4′-DDT CAS:50-29-3 EC:200-024-3, 100 mg in 2 ml vial |
LK2-CRM4201-1566 |
|
| 4,4′-Methylene bis(N,N-dimethylaniline) CAS:101-61-1 EC:202-959-2, 250 mg in 4 ml vial |
LK2-CRM4201-1567 |
|
| 4,4′-Sulfonyldiphenol CAS:80-09-1 EC:201-250-5, 100 mg in 2 ml vial |
LK2-CRM4201-1568 |
|
| 4-Aminobenzamide CAS:2835-68-9 EC:220-612-3, 100 mg in 2 ml vial |
LK2-CRM4201-1569 |
|
| 4-Aminotoluene-3-sulfonic acid CAS:88-44-8 EC:201-831-3, 100 mg in 2 ml vial |
LK2-CRM4201-1570 |
|
| 4-Anisidine CAS:104-94-9 EC:203-254-2, 250 mg in 4 ml vial |
LK2-CRM4201-1571 |
|
| 4-Chloro-1,2-phenylenediamine CAS:95-83-0 EC:202-456-8, 100 mg in 2 ml vial |
LK2-CRM4201-1572 |
|
| 4-Chloro-1,3-phenylenediamine CAS:5131-60-2 EC:225-877-9, 100 mg in 2 ml vial |
LK2-CRM4201-1573 |
|
| 4-Cyano-1-cyclohexene CAS:100-45-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1574 |
|
| 4-Ethylguaiacol CAS:2785-89-9 EC:220-500-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1575 |
|
| 4-Methyl-2-nitroaniline CAS:89-62-3 EC:201-924-9, 250 mg in 4 ml vial |
LK2-CRM4201-1576 |
|
| 4-Methylcyclohexane-1,2-dicarboxylic Anhydride CAS:19438-60-9 EC:243-072-0, 100 mg in 2 ml vial |
LK2-CRM4201-1577 |
|
| 4-Methyldibenzothiophene CAS:7372-88-5, 100 mg in 2 ml vial |
LK2-CRM4201-1578 |
|
| 4-Nitroanisole CAS:100-17-4 EC:202-825-3, 100 mg in 2 ml vial |
LK2-CRM4201-1579 |
|
| 4-Nitro-o-phenylenediamine CAS:99-56-9 EC:202-766-3, 100 mg in 2 ml vial |
LK2-CRM4201-1580 |
|
| 4-Nitroquinoline-N-oxide CAS:56-57-5 EC:200-281-1, 100 mg in 2 ml vial |
LK2-CRM4201-1581 |
|
| 4-Nonylphenol (technical) CAS:84852-15-3 EC:284-325-5, 100 mg in 2 ml vial |
LK2-CRM4201-1582 |
|
| 4-Phenyl-1-cyclohexene CAS:4994-16-5, 100 mg in 1 ml ampoule |
LK2-CRM4201-1583 |
|
| 4-tert-Butylcatechol CAS:98-29-3 EC:202-653-9, 100 mg in 2 ml vial |
LK2-CRM4201-1584 |
|
| 4-Vinylcyclohexene dioxide CAS:106-87-6 EC:203-437-7, 50 mg in 2 ml vial |
LK2-CRM4201-1585 |
|
| 5-(Hydroxymethyl)furfural CAS:67-47-0 EC:200-654-9, 100 mg in 2 ml vial |
LK2-CRM4201-1586 |
|
| Isophorone diamine, mixture of cis and trans CAS:2855-13-2 EC:220-666-8, 100 mg in 2 ml vial |
LK2-CRM4201-1587 |
|
| 5-Ethylidene-2-norbornene CAS:16219-75-3 EC:240-347-7, 100 mg in 2 ml vial |
LK2-CRM4201-1588 |
|
| 5-Methyl-1H-benzotriazole CAS:136-85-6 EC:205-265-8, 100 mg in 2 ml vial |
LK2-CRM4201-1589 |
|
| 5-Methyl-benzobthiophene-2-carbaldehyde CAS:27035-41-2, 100 mg in 2 ml vial |
LK2-CRM4201-1590 |
|
| 5-Methylfurfural CAS:620-02-0 EC:210-622-6, 0,25 ml in 1 ml ampoule |
LK2-CRM4201-1591 |
|
| 5-Nitro-o-anisidine CAS:99-59-2 EC:202-770-5, 100 mg in 2 ml vial |
LK2-CRM4201-1592 |
|
| 6-Amino-4-chloro-m-toluenesulfonic acid CAS:88-51-7 EC:201-837-6, 100 mg in 2 ml vial |
LK2-CRM4201-1593 |
|
| 8-Hydroxyquinoline CAS:148-24-3 EC:205-711-1, 250 mg in 2 ml vial |
LK2-CRM4201-1594 |
|
| 9-Nitroanthracene CAS:602-60-8 EC:210-021-9, 100 mg in 2 ml vial |
LK2-CRM4201-1595 |
|
| Acetaldehyde diethylacetal CAS:105-57-7 EC:203-310-6, 1ml in 1 ml ampoule |
LK2-CRM4201-1596 |
|
| Acetamide CAS:60-35-5 EC:200-473-5, 100 mg in 2 ml vial |
LK2-CRM4201-1597 |
|
| Acetophenone CAS:98-86-2 EC:202-708-7, 1 ml in 1 ml ampoule |
LK2-CRM4201-1598 |
|
| Acifluorfen CAS:50594-66-6 EC:256-634-5, 50 mg in 2 ml vial |
LK2-CRM4201-1599 |
|
| Acrylamide CAS:79-06-1 EC:201-173-7, 100 mg in 2 ml vial |
LK2-CRM4201-1600 |
|
| alpha-Humulene CAS:6753-98-6 EC:229-816-7, 0,5 ml in 1 ml ampoule |
LK2-CRM4201-1601 |
|
| alpha-Phellandrene CAS:99-83-2 EC:202-792-5, 100 mg in 1 ml ampoule |
LK2-CRM4201-1602 |
|
| Amitraz CAS:33089-61-1 EC:251-375-4, 100 mg in 2 ml vial |
LK2-CRM4201-1603 |
|
| Aniline hydrochloride CAS:142-04-1 EC:205-519-8, 100 mg in 2 ml vial |
LK2-CRM4201-1604 |
|
| Anisole CAS:100-66-3 EC:202-876-1, 100 mg in 2 ml vial |
LK2-CRM4201-1605 |
|
| Anthranilic acid isopropylamide CAS:30391-89-0 EC:250-175-4, 100 mg in 2 ml vial |
LK2-CRM4201-1606 |
|
| Anthraquinone CAS:84-65-1 EC:201-549-0, 250 mg in 2 ml vial |
LK2-CRM4201-1607 |
|
| Aroclor 1268 CAS:11100-14-4, 100 mg in 2 ml vial |
LK2-CRM4201-1608 |
|
| a-Terpineol CAS:98-55-5 EC:202-680-6, 250 mg in 4 ml vial |
LK2-CRM4201-1609 |
|
| 2,4-Dimethylaniline CAS:95-68-1 EC:202-440-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1610 |
|
| 2-Acetamidofluorene CAS:53-96-3 EC:200-188-6, 100 mg in 2 ml vial |
LK2-CRM4201-1611 |
|
| 2-Amino-1-naphthalenesulfonic acid CAS:81-16-3 EC:201-331-5, 100 mg in 2 ml vial |
LK2-CRM4201-1612 |
|
| 2-Amino-5-chloro-p-toluenesulfonic Acid CAS:88-53-9 EC:201-839-7, 100 mg in 2 ml vial |
LK2-CRM4201-1613 |
|
| 2-Aminoanthraquinone CAS:117-79-3 EC:204-208-4, 1000 mg in 4 ml vial |
LK2-CRM4201-1614 |
|
| 2-Butyloxyethyl acetate CAS:112-07-2 EC:203-933-3, 1ml in 1 ml ampoule |
LK2-CRM4201-1615 |
|
| 2-Chloro-1,1,2-trifluoroethyl difluoromethyl ether CAS:13838-16-9 EC:237-553-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1616 |
|
| 2-Chloroethyl Chloromethyl Ether CAS:1462-33-5, 100 mg in 2 ml vial |
LK2-CRM4201-1617 |
|
| 2-Ethylhexyl acrylate CAS:103-11-7 EC:203-080-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1618 |
|
| 2-Hydroxybenzothiazole CAS:934-34-9 EC:213-281-1, 100 mg in 2 ml vial |
LK2-CRM4201-1619 |
|
| 2-Hydroxyethyl methacrylate CAS:868-77-9 EC:212-782-2, 100 mg in 1 ml ampoule |
LK2-CRM4201-1620 |
|
| 2-Hydroxypropionitrile CAS:78-97-7 EC:201-163-2, 100 mg in 2 ml vial |
LK2-CRM4201-1621 |
|
| 2-Mercaptobenzothiazole CAS:149-30-4 EC:205-736-8, 1000 mg in 2 ml vial |
LK2-CRM4201-1622 |
|
| 2-Methoxy-4-nitroaniline CAS:97-52-9 EC:202-588-6, 100 mg in 2 ml vial |
LK2-CRM4201-1623 |
|
| 2-Methyl-1,3-dioxolane CAS:497-26-7 EC:207-841-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1624 |
|
| 2-Methylbenzothiazole CAS:120-75-2 EC:204-423-3, 100 mg in 2 ml vial |
LK2-CRM4201-1625 |
|
| 2-Methylstyrene (stabilized with TBC) CAS:611-15-4 EC:210-256-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1547 |
|
| 2-Nitrofluorene CAS:607-57-8 EC:210-138-5, 100 mg in 2 ml vial |
LK2-CRM4201-1548 |
|
| 2-Octyl-4-isothiazolin-3-one CAS:26530-20-1 EC:247-761-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1549 |
|
| 2-Picoline CAS:109-06-8 EC:203-643-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1550 |
|
| 2-Propanethiol CAS:75-33-2 EC:200-861-4, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1551 |
|
| 3-(Chloromethyl) pyridine hydrochloride CAS:6959-48-4 EC:230-150-4, 100 mg in 2 ml vial |
LK2-CRM4201-1552 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1553 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1554 |
|
| 3,3′-Dimethylbenzidine CAS:119-93-7 EC:204-358-0, 100 mg in 2 ml vial |
LK2-CRM4201-1555 |
|
| 3,6-Dichloropyridazine CAS:141-30-0 EC:205-478-6, 100 mg in 2 ml vial |
LK2-CRM4201-1556 |
|
| 3-Amino-4-methoxybenzanilide CAS:120-35-4 EC:204-388-4, 100 mg in 2 ml vial |
LK2-CRM4201-1557 |
|
| 3-Amino-4-methylbenzamide CAS:19406-86-1 EC:243-039-0, 100 mg in 2 ml vial |
LK2-CRM4201-1558 |
|
| 3-Amino-9-ethylcarbazole CAS:132-32-1 EC:205-057-7, 52 mg in 1 ml ampoule |
LK2-CRM4201-1559 |
|
| 3-Anisidine CAS:536-90-3 EC:208-651-4, 250 mg in 1 ml ampoule |
LK2-CRM4201-1560 |
|
| 3-Chloropropionitrile CAS:542-76-7 EC:208-827-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1561 |
|
| 3-Diethylaminopropionitrile CAS:5351-04-2 EC:226-323-9, 100 mg in 2 ml vial |
LK2-CRM4201-1562 |
|
| 3-Ethoxy-1-propanol CAS:111-35-3 EC:203-861-2, 100 mg in 2 ml vial |
LK2-CRM4201-1563 |
|
| 3-Methylbenzothiophene CAS:1455-18-1 EC:215-934-6, 100 mg in 2 ml vial |
LK2-CRM4201-1564 |
|
| 4,4′-Bis(dimethylamino)benzophenone CAS:90-94-8 EC:202-027-5, 100 mg in 2 ml vial |
LK2-CRM4201-1565 |
|
| 4,4′-DDT CAS:50-29-3 EC:200-024-3, 100 mg in 2 ml vial |
LK2-CRM4201-1566 |
|
| 4,4′-Methylene bis(N,N-dimethylaniline) CAS:101-61-1 EC:202-959-2, 250 mg in 4 ml vial |
LK2-CRM4201-1567 |
|
| 4,4′-Sulfonyldiphenol CAS:80-09-1 EC:201-250-5, 100 mg in 2 ml vial |
LK2-CRM4201-1568 |
|
| 4-Aminobenzamide CAS:2835-68-9 EC:220-612-3, 100 mg in 2 ml vial |
LK2-CRM4201-1569 |
|
| 4-Aminotoluene-3-sulfonic acid CAS:88-44-8 EC:201-831-3, 100 mg in 2 ml vial |
LK2-CRM4201-1570 |
|
| 4-Anisidine CAS:104-94-9 EC:203-254-2, 250 mg in 4 ml vial |
LK2-CRM4201-1571 |
|
| 4-Chloro-1,2-phenylenediamine CAS:95-83-0 EC:202-456-8, 100 mg in 2 ml vial |
LK2-CRM4201-1572 |
|
| 4-Chloro-1,3-phenylenediamine CAS:5131-60-2 EC:225-877-9, 100 mg in 2 ml vial |
LK2-CRM4201-1573 |
|
| 4-Cyano-1-cyclohexene CAS:100-45-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1574 |
|
| 4-Ethylguaiacol CAS:2785-89-9 EC:220-500-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1575 |
|
| 4-Methyl-2-nitroaniline CAS:89-62-3 EC:201-924-9, 250 mg in 4 ml vial |
LK2-CRM4201-1576 |
|
| 4-Methylcyclohexane-1,2-dicarboxylic Anhydride CAS:19438-60-9 EC:243-072-0, 100 mg in 2 ml vial |
LK2-CRM4201-1577 |
|
| 4-Methyldibenzothiophene CAS:7372-88-5, 100 mg in 2 ml vial |
LK2-CRM4201-1578 |
|
| 4-Nitroanisole CAS:100-17-4 EC:202-825-3, 100 mg in 2 ml vial |
LK2-CRM4201-1579 |
|
| 4-Nitro-o-phenylenediamine CAS:99-56-9 EC:202-766-3, 100 mg in 2 ml vial |
LK2-CRM4201-1580 |
|
| 1-Methyl-1H-benzotriazole CAS:13351-73-0 EC:236-401-4, 100 mg in 2 ml vial |
LK2-CRM4201-1502 |
|
| (+)-alpha-Pinene CAS:7785-70-8 EC:232-087-8, 100 mg in ml in 1 ml ampoule |
LK2-CRM4201-1503 |
|
| (R)-(+)-Limonene CAS:5989-27-5 EC:227-813-5, 100 mg in 1 ml ampoule |
LK2-CRM4201-1504 |
|
| 1-(2-Pyridyl)piperazine CAS:34803-66-2 EC:252-220-3, 100 mg in 1 ml ampoule |
LK2-CRM4201-1505 |
|
| 1,2-Benzisothiazol-3(2H)-one CAS:2634-33-5 EC:220-120-9, 100 mg in 2 ml vial |
LK2-CRM4201-1506 |
|
| 1,2-Cyclohexanedicarboxylic anhydride, predominantly cis CAS:85-42-7 EC:201-604-9, 100 mg in 2 ml vial |
LK2-CRM4201-1507 |
|
| 1,3-Bis(2-isocyanato-2-propyl)benzene CAS:2778-42-9 EC:220-474-4, 250 mg in 1 ml ampoule |
LK2-CRM4201-1508 |
|
| 1,4-Diazabicyclo2.2.2octane CAS:280-57-9 EC:205-999-9, 100 mg in 2 ml vial |
LK2-CRM4201-1509 |
|
| 1,4-Phenylenediamine CAS:106-50-3 EC:203-404-7, 100 mg in 2 ml vial |
LK2-CRM4201-1510 |
|
| 1,5-Cyclooctadiene CAS:111-78-4 l EC:203-907-1, 100 mg in 2 ml vial |
LK2-CRM4201-1511 |
|
| 1.2-Naphthoquinone CAS:524-42-5 EC:208-360-2, 100 mg in 2 ml vial |
LK2-CRM4201-1512 |
|
| 1.4-Naphthoquinone CAS:130-15-4 l EC:204-977-6, 250mg in 2 ml vial |
LK2-CRM4201-1513 |
|
| 1-Acetyl-2-thiourea CAS:591-08-2 EC:209-699-9, 100 mg in 2 ml vial1-Ethyl-2-pyrrolidone CAS:2687-91-4 EC:220-250-6, 100 mg in 1 ml ampoule |
LK2-CRM4201-1514 |
|
| 1-Ethyl-2-pyrrolidone CAS:2687-91-4 EC:220-250-6, 100 mg in 1 ml ampoule |
LK2-CRM4201-1515 |
|
| 1H-Benzotriazole CAS:95-14-7 EC:202-394-1, 100 mg in 2 ml vial |
LK2-CRM4201-1516 |
|
| 1-Hexadecene CAS:629-73-2 EC:211-105-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1517 |
|
| 1-Naphthyl acetic acid CAS:86-87-3 EC:201-705-8, 500 mg in 2 ml vial |
LK2-CRM4201-1518 |
|
| 1-Nonadecene CAS:18435-45-5 EC:242-313-7, 100 mg in 2 ml vial |
LK2-CRM4201-1519 |
|
| 1-Propanethiol CAS:107-03-9 EC:203-455-5, 0,5 ml in 1 ml ampoule |
LK2-CRM4201-1520 |
|
| 2-(2H-Benzotriazol-2-yl)-4,6-di-tert-pentylphenol CAS:25973-55-1 EC:247-384-8, 100 mg in 2 ml vial |
LK2-CRM4201-1521 |
|
| 2-(Methylthio)benzothiazole CAS:615-22-5 EC:210-417-1, 100 mg in 2 ml vial |
LK2-CRM4201-1522 |
|
| 2,2,4-Trimethyl-1,3-pentanediol Diisobutyrate CAS:6846-50-0 EC:229-934-9, 1ml in 1 ml ampoule |
LK2-CRM4201-1523 |
|
| 1,1,3,3,5,5-Hexamethyltrisiloxane CAS:1189-93-1 EC:214-716-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1524 |
|
| 2,4,6-Tribromoanisole CAS:607-99-8, 100 mg in 2 ml vial |
LK2-CRM4201-1525 |
|
| 2,4,6-Trichloroanisole CAS:87-40-1 EC:201-743-5, 100 mg in 2 ml vial |
LK2-CRM4201-1526 |
|
| 2,4,7,9-Tetramethyl-5-decyne-4,7-diol CAS:126-86-3 EC:204-809-1, 100 mg in 2 ml vial |
LK2-CRM4201-1527 |
|
| 2,4-D CAS:94-75-7 EC:202-361-1, 100 mg in 2 ml vial |
LK2-CRM4201-1528 |
|
| 2,4-Diaminoanisole Sulfate Hydrate CAS:6219-67-6 EC:228-290-6, 100 mg in 2 ml vial |
LK2-CRM4201-1529 |
|
| 2,4-Dichlorobenzyl chloride CAS:94-99-5 EC:202-381-0, 100 mg in 1 ml ampoule |
LK2-CRM4201-1530 |
|
| 2,4-Dimethylaniline CAS:95-68-1 EC:202-440-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1531 |
|
| 2-Acetamidofluorene CAS:53-96-3 EC:200-188-6, 100 mg in 2 ml vial |
LK2-CRM4201-1532 |
|
| 2-Amino-1-naphthalenesulfonic acid CAS:81-16-3 EC:201-331-5, 100 mg in 2 ml vial |
LK2-CRM4201-1533 |
|
| 2-Amino-5-chloro-p-toluenesulfonic Acid CAS:88-53-9 EC:201-839-7, 100 mg in 2 ml vial |
LK2-CRM4201-1534 |
|
| 2-Aminoanthraquinone CAS:117-79-3 EC:204-208-4, 1000 mg in 4 ml vial |
LK2-CRM4201-1535 |
|
| 2-Butyloxyethyl acetate CAS:112-07-2 EC:203-933-3, 1ml in 1 ml ampoule |
LK2-CRM4201-1536 |
|
| 2-Chloro-1,1,2-trifluoroethyl difluoromethyl ether CAS:13838-16-9 EC:237-553-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1537 |
|
| 2-Chloroethyl Chloromethyl Ether CAS:1462-33-5, 100 mg in 2 ml vial |
LK2-CRM4201-1538 |
|
| 2-Ethylhexyl acrylate CAS:103-11-7 EC:203-080-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1539 |
|
| 2-Hydroxybenzothiazole CAS:934-34-9 EC:213-281-1, 100 mg in 2 ml vial |
LK2-CRM4201-1540 |
|
| 2-Hydroxyethyl methacrylate CAS:868-77-9 EC:212-782-2, 100 mg in 1 ml ampoule |
LK2-CRM4201-1541 |
|
| 2-Hydroxypropionitrile CAS:78-97-7 EC:201-163-2, 100 mg in 2 ml vial |
LK2-CRM4201-1542 |
|
| 2-Mercaptobenzothiazole CAS:149-30-4 EC:205-736-8, 1000 mg in 2 ml vial |
LK2-CRM4201-1543 |
|
| 2-Methoxy-4-nitroaniline CAS:97-52-9 EC:202-588-6, 100 mg in 2 ml vial |
LK2-CRM4201-1544 |
|
| 2-Methyl-1,3-dioxolane CAS:497-26-7 EC:207-841-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1545 |
|
| 2-Methylbenzothiazole CAS:120-75-2 EC:204-423-3, 100 mg in 2 ml vial |
LK2-CRM4201-1546 |
|
| 2-Methylstyrene (stabilized with TBC) CAS:611-15-4 EC:210-256-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1547 |
|
| 2-Nitrofluorene CAS:607-57-8 EC:210-138-5, 100 mg in 2 ml vial |
LK2-CRM4201-1548 |
|
| 2-Octyl-4-isothiazolin-3-one CAS:26530-20-1 EC:247-761-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1549 |
|
| 2-Picoline CAS:109-06-8 EC:203-643-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1550 |
|
| 2-Propanethiol CAS:75-33-2 EC:200-861-4, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1551 |
|
| 3-(Chloromethyl) pyridine hydrochloride CAS:6959-48-4 EC:230-150-4, 100 mg in 2 ml vial |
LK2-CRM4201-1552 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1553 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1554 |
|
| 3,3′-Dimethylbenzidine CAS:119-93-7 EC:204-358-0, 100 mg in 2 ml vial |
LK2-CRM4201-1555 |
|
| 3,6-Dichloropyridazine CAS:141-30-0 EC:205-478-6, 100 mg in 2 ml vial |
LK2-CRM4201-1556 |
|
| 3-Amino-4-methoxybenzanilide CAS:120-35-4 EC:204-388-4, 100 mg in 2 ml vial |
LK2-CRM4201-1557 |
|
| 3-Amino-4-methylbenzamide CAS:19406-86-1 EC:243-039-0, 100 mg in 2 ml vial |
LK2-CRM4201-1558 |
|
| 3-Amino-9-ethylcarbazole CAS:132-32-1 EC:205-057-7, 52 mg in 1 ml ampoule |
LK2-CRM4201-1559 |
|
| 3-Anisidine CAS:536-90-3 EC:208-651-4, 250 mg in 1 ml ampoule |
LK2-CRM4201-1560 |
|
| 3-Chloropropionitrile CAS:542-76-7 EC:208-827-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1561 |
|
| 3-Diethylaminopropionitrile CAS:5351-04-2 EC:226-323-9, 100 mg in 2 ml vial |
LK2-CRM4201-1562 |
|
| 3-Ethoxy-1-propanol CAS:111-35-3 EC:203-861-2, 100 mg in 2 ml vial |
LK2-CRM4201-1563 |
|
| 3-Methylbenzothiophene CAS:1455-18-1 EC:215-934-6, 100 mg in 2 ml vial |
LK2-CRM4201-1564 |
|
| 4,4′-Bis(dimethylamino)benzophenone CAS:90-94-8 EC:202-027-5, 100 mg in 2 ml vial |
LK2-CRM4201-1565 |
|
| 4,4′-DDT CAS:50-29-3 EC:200-024-3, 100 mg in 2 ml vial |
LK2-CRM4201-1566 |
|
| 4,4′-Methylene bis(N,N-dimethylaniline) CAS:101-61-1 EC:202-959-2, 250 mg in 4 ml vial |
LK2-CRM4201-1567 |
|
| 4,4′-Sulfonyldiphenol CAS:80-09-1 EC:201-250-5, 100 mg in 2 ml vial |
LK2-CRM4201-1568 |
|
| 4-Aminobenzamide CAS:2835-68-9 EC:220-612-3, 100 mg in 2 ml vial |
LK2-CRM4201-1569 |
|
| 4-Aminotoluene-3-sulfonic acid CAS:88-44-8 EC:201-831-3, 100 mg in 2 ml vial |
LK2-CRM4201-1570 |
|
| 4-Anisidine CAS:104-94-9 EC:203-254-2, 250 mg in 4 ml vial |
LK2-CRM4201-1571 |
|
| 4-Chloro-1,2-phenylenediamine CAS:95-83-0 EC:202-456-8, 100 mg in 2 ml vial |
LK2-CRM4201-1572 |
|
| 4-Chloro-1,3-phenylenediamine CAS:5131-60-2 EC:225-877-9, 100 mg in 2 ml vial |
LK2-CRM4201-1573 |
|
| 4-Cyano-1-cyclohexene CAS:100-45-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1574 |
|
| 4-Ethylguaiacol CAS:2785-89-9 EC:220-500-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1575 |
|
| 4-Methyl-2-nitroaniline CAS:89-62-3 EC:201-924-9, 250 mg in 4 ml vial |
LK2-CRM4201-1576 |
|
| 4-Methylcyclohexane-1,2-dicarboxylic Anhydride CAS:19438-60-9 EC:243-072-0, 100 mg in 2 ml vial |
LK2-CRM4201-1577 |
|
| 4-Methyldibenzothiophene CAS:7372-88-5, 100 mg in 2 ml vial |
LK2-CRM4201-1578 |
|
| 4-Nitroanisole CAS:100-17-4 EC:202-825-3, 100 mg in 2 ml vial |
LK2-CRM4201-1579 |
|
| 4-Nitro-o-phenylenediamine CAS:99-56-9 EC:202-766-3, 100 mg in 2 ml vial |
LK2-CRM4201-1580 |
|
| 1-Methyl-1H-benzotriazole CAS:13351-73-0 EC:236-401-4, 100 mg in 2 ml vial |
LK2-CRM4201-1502 |
|
| (+)-alpha-Pinene CAS:7785-70-8 EC:232-087-8, 100 mg in ml in 1 ml ampoule |
LK2-CRM4201-1503 |
|
| (R)-(+)-Limonene CAS:5989-27-5 EC:227-813-5, 100 mg in 1 ml ampoule |
LK2-CRM4201-1504 |
|
| 1-(2-Pyridyl)piperazine CAS:34803-66-2 EC:252-220-3, 100 mg in 1 ml ampoule |
LK2-CRM4201-1505 |
|
| 1,2-Benzisothiazol-3(2H)-one CAS:2634-33-5 EC:220-120-9, 100 mg in 2 ml vial |
LK2-CRM4201-1506 |
|
| 1,2-Cyclohexanedicarboxylic anhydride, predominantly cis CAS:85-42-7 EC:201-604-9, 100 mg in 2 ml vial |
LK2-CRM4201-1507 |
|
| 1,3-Bis(2-isocyanato-2-propyl)benzene CAS:2778-42-9 EC:220-474-4, 250 mg in 1 ml ampoule |
LK2-CRM4201-1508 |
|
| 1,4-Diazabicyclo2.2.2octane CAS:280-57-9 EC:205-999-9, 100 mg in 2 ml vial |
LK2-CRM4201-1509 |
|
| 1,4-Phenylenediamine CAS:106-50-3 EC:203-404-7, 100 mg in 2 ml vial |
LK2-CRM4201-1510 |
|
| 1,5-Cyclooctadiene CAS:111-78-4 l EC:203-907-1, 100 mg in 2 ml vial |
LK2-CRM4201-1511 |
|
| 1.2-Naphthoquinone CAS:524-42-5 EC:208-360-2, 100 mg in 2 ml vial |
LK2-CRM4201-1512 |
|
| 1.4-Naphthoquinone CAS:130-15-4 l EC:204-977-6, 250mg in 2 ml vial |
LK2-CRM4201-1513 |
|
| 1-Acetyl-2-thiourea CAS:591-08-2 EC:209-699-9, 100 mg in 2 ml vial1-Ethyl-2-pyrrolidone CAS:2687-91-4 EC:220-250-6, 100 mg in 1 ml ampoule |
LK2-CRM4201-1514 |
|
| 1-Ethyl-2-pyrrolidone CAS:2687-91-4 EC:220-250-6, 100 mg in 1 ml ampoule |
LK2-CRM4201-1515 |
|
| 1H-Benzotriazole CAS:95-14-7 EC:202-394-1, 100 mg in 2 ml vial |
LK2-CRM4201-1516 |
|
| 1-Hexadecene CAS:629-73-2 EC:211-105-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1517 |
|
| 1-Naphthyl acetic acid CAS:86-87-3 EC:201-705-8, 500 mg in 2 ml vial |
LK2-CRM4201-1518 |
|
| 1-Nonadecene CAS:18435-45-5 EC:242-313-7, 100 mg in 2 ml vial |
LK2-CRM4201-1519 |
|
| 1-Propanethiol CAS:107-03-9 EC:203-455-5, 0,5 ml in 1 ml ampoule |
LK2-CRM4201-1520 |
|
| 2-(2H-Benzotriazol-2-yl)-4,6-di-tert-pentylphenol CAS:25973-55-1 EC:247-384-8, 100 mg in 2 ml vial |
LK2-CRM4201-1521 |
|
| 2-(Methylthio)benzothiazole CAS:615-22-5 EC:210-417-1, 100 mg in 2 ml vial |
LK2-CRM4201-1522 |
|
| 2,2,4-Trimethyl-1,3-pentanediol Diisobutyrate CAS:6846-50-0 EC:229-934-9, 1ml in 1 ml ampoule |
LK2-CRM4201-1523 |
|
| 1,1,3,3,5,5-Hexamethyltrisiloxane CAS:1189-93-1 EC:214-716-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1524 |
|
| 2,4,6-Tribromoanisole CAS:607-99-8, 100 mg in 2 ml vial |
LK2-CRM4201-1525 |
|
| 2,4,6-Trichloroanisole CAS:87-40-1 EC:201-743-5, 100 mg in 2 ml vial |
LK2-CRM4201-1526 |
|
| 2,4,7,9-Tetramethyl-5-decyne-4,7-diol CAS:126-86-3 EC:204-809-1, 100 mg in 2 ml vial |
LK2-CRM4201-1527 |
|
| 2,4-D CAS:94-75-7 EC:202-361-1, 100 mg in 2 ml vial |
LK2-CRM4201-1528 |
|
| 2,4-Diaminoanisole Sulfate Hydrate CAS:6219-67-6 EC:228-290-6, 100 mg in 2 ml vial |
LK2-CRM4201-1529 |
|
| 2,4-Dichlorobenzyl chloride CAS:94-99-5 EC:202-381-0, 100 mg in 1 ml ampoule |
LK2-CRM4201-1530 |
|
| 2,4-Dimethylaniline CAS:95-68-1 EC:202-440-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1531 |
|
| 2-Acetamidofluorene CAS:53-96-3 EC:200-188-6, 100 mg in 2 ml vial |
LK2-CRM4201-1532 |
|
| 2-Amino-1-naphthalenesulfonic acid CAS:81-16-3 EC:201-331-5, 100 mg in 2 ml vial |
LK2-CRM4201-1533 |
|
| 2-Amino-5-chloro-p-toluenesulfonic Acid CAS:88-53-9 EC:201-839-7, 100 mg in 2 ml vial |
LK2-CRM4201-1534 |
|
| 2-Aminoanthraquinone CAS:117-79-3 EC:204-208-4, 1000 mg in 4 ml vial |
LK2-CRM4201-1535 |
|
| 2-Butyloxyethyl acetate CAS:112-07-2 EC:203-933-3, 1ml in 1 ml ampoule |
LK2-CRM4201-1536 |
|
| 2-Chloro-1,1,2-trifluoroethyl difluoromethyl ether CAS:13838-16-9 EC:237-553-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1537 |
|
| 2-Chloroethyl Chloromethyl Ether CAS:1462-33-5, 100 mg in 2 ml vial |
LK2-CRM4201-1538 |
|
| 2-Ethylhexyl acrylate CAS:103-11-7 EC:203-080-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1539 |
|
| 2-Hydroxybenzothiazole CAS:934-34-9 EC:213-281-1, 100 mg in 2 ml vial |
LK2-CRM4201-1540 |
|
| 2-Hydroxyethyl methacrylate CAS:868-77-9 EC:212-782-2, 100 mg in 1 ml ampoule |
LK2-CRM4201-1541 |
|
| 2-Hydroxypropionitrile CAS:78-97-7 EC:201-163-2, 100 mg in 2 ml vial |
LK2-CRM4201-1542 |
|
| 2-Mercaptobenzothiazole CAS:149-30-4 EC:205-736-8, 1000 mg in 2 ml vial |
LK2-CRM4201-1543 |
|
| 2-Methoxy-4-nitroaniline CAS:97-52-9 EC:202-588-6, 100 mg in 2 ml vial |
LK2-CRM4201-1544 |
|
| 2-Methyl-1,3-dioxolane CAS:497-26-7 EC:207-841-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1545 |
|
| 2-Methylbenzothiazole CAS:120-75-2 EC:204-423-3, 100 mg in 2 ml vial |
LK2-CRM4201-1546 |
|
| 2-Methylstyrene (stabilized with TBC) CAS:611-15-4 EC:210-256-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1547 |
|
| 2-Nitrofluorene CAS:607-57-8 EC:210-138-5, 100 mg in 2 ml vial |
LK2-CRM4201-1548 |
|
| 2-Octyl-4-isothiazolin-3-one CAS:26530-20-1 EC:247-761-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1549 |
|
| 2-Picoline CAS:109-06-8 EC:203-643-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1550 |
|
| 2-Propanethiol CAS:75-33-2 EC:200-861-4, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1551 |
|
| 3-(Chloromethyl) pyridine hydrochloride CAS:6959-48-4 EC:230-150-4, 100 mg in 2 ml vial |
LK2-CRM4201-1552 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1553 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1554 |
|
| 3,3′-Dimethylbenzidine CAS:119-93-7 EC:204-358-0, 100 mg in 2 ml vial |
LK2-CRM4201-1555 |
|
| 3,6-Dichloropyridazine CAS:141-30-0 EC:205-478-6, 100 mg in 2 ml vial |
LK2-CRM4201-1556 |
|
| 3-Amino-4-methoxybenzanilide CAS:120-35-4 EC:204-388-4, 100 mg in 2 ml vial |
LK2-CRM4201-1557 |
|
| 3-Amino-4-methylbenzamide CAS:19406-86-1 EC:243-039-0, 100 mg in 2 ml vial |
LK2-CRM4201-1558 |
|
| 3-Amino-9-ethylcarbazole CAS:132-32-1 EC:205-057-7, 52 mg in 1 ml ampoule |
LK2-CRM4201-1559 |
|
| 3-Anisidine CAS:536-90-3 EC:208-651-4, 250 mg in 1 ml ampoule |
LK2-CRM4201-1560 |
|
| 3-Chloropropionitrile CAS:542-76-7 EC:208-827-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1561 |
|
| 3-Diethylaminopropionitrile CAS:5351-04-2 EC:226-323-9, 100 mg in 2 ml vial |
LK2-CRM4201-1562 |
|
| 3-Ethoxy-1-propanol CAS:111-35-3 EC:203-861-2, 100 mg in 2 ml vial |
LK2-CRM4201-1563 |
|
| 3-Methylbenzothiophene CAS:1455-18-1 EC:215-934-6, 100 mg in 2 ml vial |
LK2-CRM4201-1564 |
|
| 4,4′-Bis(dimethylamino)benzophenone CAS:90-94-8 EC:202-027-5, 100 mg in 2 ml vial |
LK2-CRM4201-1565 |
|
| 4,4′-DDT CAS:50-29-3 EC:200-024-3, 100 mg in 2 ml vial |
LK2-CRM4201-1566 |
|
| 4,4′-Methylene bis(N,N-dimethylaniline) CAS:101-61-1 EC:202-959-2, 250 mg in 4 ml vial |
LK2-CRM4201-1567 |
|
| 4,4′-Sulfonyldiphenol CAS:80-09-1 EC:201-250-5, 100 mg in 2 ml vial |
LK2-CRM4201-1568 |
|
| 4-Aminobenzamide CAS:2835-68-9 EC:220-612-3, 100 mg in 2 ml vial |
LK2-CRM4201-1569 |
|
| 4-Aminotoluene-3-sulfonic acid CAS:88-44-8 EC:201-831-3, 100 mg in 2 ml vial |
LK2-CRM4201-1570 |
|
| 4-Anisidine CAS:104-94-9 EC:203-254-2, 250 mg in 4 ml vial |
LK2-CRM4201-1571 |
|
| 4-Chloro-1,2-phenylenediamine CAS:95-83-0 EC:202-456-8, 100 mg in 2 ml vial |
LK2-CRM4201-1572 |
|
| 4-Chloro-1,3-phenylenediamine CAS:5131-60-2 EC:225-877-9, 100 mg in 2 ml vial |
LK2-CRM4201-1573 |
|
| 4-Cyano-1-cyclohexene CAS:100-45-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1574 |
|
| 4-Ethylguaiacol CAS:2785-89-9 EC:220-500-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1575 |
|
| 4-Methyl-2-nitroaniline CAS:89-62-3 EC:201-924-9, 250 mg in 4 ml vial |
LK2-CRM4201-1576 |
|
| 4-Methylcyclohexane-1,2-dicarboxylic Anhydride CAS:19438-60-9 EC:243-072-0, 100 mg in 2 ml vial |
LK2-CRM4201-1577 |
|
| 4-Methyldibenzothiophene CAS:7372-88-5, 100 mg in 2 ml vial |
LK2-CRM4201-1578 |
|
| 4-Nitroanisole CAS:100-17-4 EC:202-825-3, 100 mg in 2 ml vial |
LK2-CRM4201-1579 |
|
| 4-Nitro-o-phenylenediamine CAS:99-56-9 EC:202-766-3, 100 mg in 2 ml vial |
LK2-CRM4201-1580 |
|
| 1-Methyl-1H-benzotriazole CAS:13351-73-0 EC:236-401-4, 100 mg in 2 ml vial |
LK2-CRM4201-1502 |
|
| (+)-alpha-Pinene CAS:7785-70-8 EC:232-087-8, 100 mg in ml in 1 ml ampoule |
LK2-CRM4201-1503 |
|
| (R)-(+)-Limonene CAS:5989-27-5 EC:227-813-5, 100 mg in 1 ml ampoule |
LK2-CRM4201-1504 |
|
| 1-(2-Pyridyl)piperazine CAS:34803-66-2 EC:252-220-3, 100 mg in 1 ml ampoule |
LK2-CRM4201-1505 |
|
| 1,2-Benzisothiazol-3(2H)-one CAS:2634-33-5 EC:220-120-9, 100 mg in 2 ml vial |
LK2-CRM4201-1506 |
|
| 1,2-Cyclohexanedicarboxylic anhydride, predominantly cis CAS:85-42-7 EC:201-604-9, 100 mg in 2 ml vial |
LK2-CRM4201-1507 |
|
| 1,3-Bis(2-isocyanato-2-propyl)benzene CAS:2778-42-9 EC:220-474-4, 250 mg in 1 ml ampoule |
LK2-CRM4201-1508 |
|
| 1,4-Diazabicyclo2.2.2octane CAS:280-57-9 EC:205-999-9, 100 mg in 2 ml vial |
LK2-CRM4201-1509 |
|
| 1,4-Phenylenediamine CAS:106-50-3 EC:203-404-7, 100 mg in 2 ml vial |
LK2-CRM4201-1510 |
|
| 1,5-Cyclooctadiene CAS:111-78-4 l EC:203-907-1, 100 mg in 2 ml vial |
LK2-CRM4201-1511 |
|
| 1.2-Naphthoquinone CAS:524-42-5 EC:208-360-2, 100 mg in 2 ml vial |
LK2-CRM4201-1512 |
|
| 1.4-Naphthoquinone CAS:130-15-4 l EC:204-977-6, 250mg in 2 ml vial |
LK2-CRM4201-1513 |
|
| 1-Acetyl-2-thiourea CAS:591-08-2 EC:209-699-9, 100 mg in 2 ml vial1-Ethyl-2-pyrrolidone CAS:2687-91-4 EC:220-250-6, 100 mg in 1 ml ampoule |
LK2-CRM4201-1514 |
|
| 1-Ethyl-2-pyrrolidone CAS:2687-91-4 EC:220-250-6, 100 mg in 1 ml ampoule |
LK2-CRM4201-1515 |
|
| 1H-Benzotriazole CAS:95-14-7 EC:202-394-1, 100 mg in 2 ml vial |
LK2-CRM4201-1516 |
|
| 1-Hexadecene CAS:629-73-2 EC:211-105-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1517 |
|
| 1-Naphthyl acetic acid CAS:86-87-3 EC:201-705-8, 500 mg in 2 ml vial |
LK2-CRM4201-1518 |
|
| 1-Nonadecene CAS:18435-45-5 EC:242-313-7, 100 mg in 2 ml vial |
LK2-CRM4201-1519 |
|
| 1-Propanethiol CAS:107-03-9 EC:203-455-5, 0,5 ml in 1 ml ampoule |
LK2-CRM4201-1520 |
|
| 2-(2H-Benzotriazol-2-yl)-4,6-di-tert-pentylphenol CAS:25973-55-1 EC:247-384-8, 100 mg in 2 ml vial |
LK2-CRM4201-1521 |
|
| 2-(Methylthio)benzothiazole CAS:615-22-5 EC:210-417-1, 100 mg in 2 ml vial |
LK2-CRM4201-1522 |
|
| 2,2,4-Trimethyl-1,3-pentanediol Diisobutyrate CAS:6846-50-0 EC:229-934-9, 1ml in 1 ml ampoule |
LK2-CRM4201-1523 |
|
| 1,1,3,3,5,5-Hexamethyltrisiloxane CAS:1189-93-1 EC:214-716-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1524 |
|
| 2,4,6-Tribromoanisole CAS:607-99-8, 100 mg in 2 ml vial |
LK2-CRM4201-1525 |
|
| 2,4,6-Trichloroanisole CAS:87-40-1 EC:201-743-5, 100 mg in 2 ml vial |
LK2-CRM4201-1526 |
|
| 2,4,7,9-Tetramethyl-5-decyne-4,7-diol CAS:126-86-3 EC:204-809-1, 100 mg in 2 ml vial |
LK2-CRM4201-1527 |
|
| 2,4-D CAS:94-75-7 EC:202-361-1, 100 mg in 2 ml vial |
LK2-CRM4201-1528 |
|
| 2,4-Diaminoanisole Sulfate Hydrate CAS:6219-67-6 EC:228-290-6, 100 mg in 2 ml vial |
LK2-CRM4201-1529 |
|
| 2,4-Dichlorobenzyl chloride CAS:94-99-5 EC:202-381-0, 100 mg in 1 ml ampoule |
LK2-CRM4201-1530 |
|
| 2,4-Dimethylaniline CAS:95-68-1 EC:202-440-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1531 |
|
| 2-Acetamidofluorene CAS:53-96-3 EC:200-188-6, 100 mg in 2 ml vial |
LK2-CRM4201-1532 |
|
| 2-Amino-1-naphthalenesulfonic acid CAS:81-16-3 EC:201-331-5, 100 mg in 2 ml vial |
LK2-CRM4201-1533 |
|
| 2-Amino-5-chloro-p-toluenesulfonic Acid CAS:88-53-9 EC:201-839-7, 100 mg in 2 ml vial |
LK2-CRM4201-1534 |
|
| 2-Aminoanthraquinone CAS:117-79-3 EC:204-208-4, 1000 mg in 4 ml vial |
LK2-CRM4201-1535 |
|
| 2-Butyloxyethyl acetate CAS:112-07-2 EC:203-933-3, 1ml in 1 ml ampoule |
LK2-CRM4201-1536 |
|
| 2-Chloro-1,1,2-trifluoroethyl difluoromethyl ether CAS:13838-16-9 EC:237-553-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1537 |
|
| 2-Chloroethyl Chloromethyl Ether CAS:1462-33-5, 100 mg in 2 ml vial |
LK2-CRM4201-1538 |
|
| 2-Ethylhexyl acrylate CAS:103-11-7 EC:203-080-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1539 |
|
| 2-Hydroxybenzothiazole CAS:934-34-9 EC:213-281-1, 100 mg in 2 ml vial |
LK2-CRM4201-1540 |
|
| 2-Hydroxyethyl methacrylate CAS:868-77-9 EC:212-782-2, 100 mg in 1 ml ampoule |
LK2-CRM4201-1541 |
|
| 2-Hydroxypropionitrile CAS:78-97-7 EC:201-163-2, 100 mg in 2 ml vial |
LK2-CRM4201-1542 |
|
| 2-Mercaptobenzothiazole CAS:149-30-4 EC:205-736-8, 1000 mg in 2 ml vial |
LK2-CRM4201-1543 |
|
| 2-Methoxy-4-nitroaniline CAS:97-52-9 EC:202-588-6, 100 mg in 2 ml vial |
LK2-CRM4201-1544 |
|
| 2-Methyl-1,3-dioxolane CAS:497-26-7 EC:207-841-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1545 |
|
| 2-Methylbenzothiazole CAS:120-75-2 EC:204-423-3, 100 mg in 2 ml vial |
LK2-CRM4201-1546 |
|
| 2-Methylstyrene (stabilized with TBC) CAS:611-15-4 EC:210-256-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1547 |
|
| 2-Nitrofluorene CAS:607-57-8 EC:210-138-5, 100 mg in 2 ml vial |
LK2-CRM4201-1548 |
|
| 2-Octyl-4-isothiazolin-3-one CAS:26530-20-1 EC:247-761-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1549 |
|
| 2-Picoline CAS:109-06-8 EC:203-643-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1550 |
|
| 2-Propanethiol CAS:75-33-2 EC:200-861-4, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1551 |
|
| 3-(Chloromethyl) pyridine hydrochloride CAS:6959-48-4 EC:230-150-4, 100 mg in 2 ml vial |
LK2-CRM4201-1552 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1553 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1554 |
|
| 3,3′-Dimethylbenzidine CAS:119-93-7 EC:204-358-0, 100 mg in 2 ml vial |
LK2-CRM4201-1555 |
|
| 3,6-Dichloropyridazine CAS:141-30-0 EC:205-478-6, 100 mg in 2 ml vial |
LK2-CRM4201-1556 |
|
| 3-Amino-4-methoxybenzanilide CAS:120-35-4 EC:204-388-4, 100 mg in 2 ml vial |
LK2-CRM4201-1557 |
|
| 3-Amino-4-methylbenzamide CAS:19406-86-1 EC:243-039-0, 100 mg in 2 ml vial |
LK2-CRM4201-1558 |
|
| 3-Amino-9-ethylcarbazole CAS:132-32-1 EC:205-057-7, 52 mg in 1 ml ampoule |
LK2-CRM4201-1559 |
|
| 3-Anisidine CAS:536-90-3 EC:208-651-4, 250 mg in 1 ml ampoule |
LK2-CRM4201-1560 |
|
| 3-Chloropropionitrile CAS:542-76-7 EC:208-827-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1561 |
|
| 3-Diethylaminopropionitrile CAS:5351-04-2 EC:226-323-9, 100 mg in 2 ml vial |
LK2-CRM4201-1562 |
|
| 3-Ethoxy-1-propanol CAS:111-35-3 EC:203-861-2, 100 mg in 2 ml vial |
LK2-CRM4201-1563 |
|
| 3-Methylbenzothiophene CAS:1455-18-1 EC:215-934-6, 100 mg in 2 ml vial |
LK2-CRM4201-1564 |
|
| 4,4′-Bis(dimethylamino)benzophenone CAS:90-94-8 EC:202-027-5, 100 mg in 2 ml vial |
LK2-CRM4201-1565 |
|
| 4,4′-DDT CAS:50-29-3 EC:200-024-3, 100 mg in 2 ml vial |
LK2-CRM4201-1566 |
|
| 4,4′-Methylene bis(N,N-dimethylaniline) CAS:101-61-1 EC:202-959-2, 250 mg in 4 ml vial |
LK2-CRM4201-1567 |
|
| 4,4′-Sulfonyldiphenol CAS:80-09-1 EC:201-250-5, 100 mg in 2 ml vial |
LK2-CRM4201-1568 |
|
| 4-Aminobenzamide CAS:2835-68-9 EC:220-612-3, 100 mg in 2 ml vial |
LK2-CRM4201-1569 |
|
| 4-Aminotoluene-3-sulfonic acid CAS:88-44-8 EC:201-831-3, 100 mg in 2 ml vial |
LK2-CRM4201-1570 |
|
| 4-Anisidine CAS:104-94-9 EC:203-254-2, 250 mg in 4 ml vial |
LK2-CRM4201-1571 |
|
| 4-Chloro-1,2-phenylenediamine CAS:95-83-0 EC:202-456-8, 100 mg in 2 ml vial |
LK2-CRM4201-1572 |
|
| 4-Chloro-1,3-phenylenediamine CAS:5131-60-2 EC:225-877-9, 100 mg in 2 ml vial |
LK2-CRM4201-1573 |
|
| 4-Cyano-1-cyclohexene CAS:100-45-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1574 |
|
| 4-Ethylguaiacol CAS:2785-89-9 EC:220-500-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1575 |
|
| 4-Methyl-2-nitroaniline CAS:89-62-3 EC:201-924-9, 250 mg in 4 ml vial |
LK2-CRM4201-1576 |
|
| 4-Methylcyclohexane-1,2-dicarboxylic Anhydride CAS:19438-60-9 EC:243-072-0, 100 mg in 2 ml vial |
LK2-CRM4201-1577 |
|
| 4-Methyldibenzothiophene CAS:7372-88-5, 100 mg in 2 ml vial |
LK2-CRM4201-1578 |
|
| 4-Nitroanisole CAS:100-17-4 EC:202-825-3, 100 mg in 2 ml vial |
LK2-CRM4201-1579 |
|
| 4-Nitro-o-phenylenediamine CAS:99-56-9 EC:202-766-3, 100 mg in 2 ml vial |
LK2-CRM4201-1580 |
|
| 1-Methyl-1H-benzotriazole CAS:13351-73-0 EC:236-401-4, 100 mg in 2 ml vial |
LK2-CRM4201-1502 |
|
| (+)-alpha-Pinene CAS:7785-70-8 EC:232-087-8, 100 mg in ml in 1 ml ampoule |
LK2-CRM4201-1503 |
|
| (R)-(+)-Limonene CAS:5989-27-5 EC:227-813-5, 100 mg in 1 ml ampoule |
LK2-CRM4201-1504 |
|
| 1-(2-Pyridyl)piperazine CAS:34803-66-2 EC:252-220-3, 100 mg in 1 ml ampoule |
LK2-CRM4201-1505 |
|
| 1,2-Benzisothiazol-3(2H)-one CAS:2634-33-5 EC:220-120-9, 100 mg in 2 ml vial |
LK2-CRM4201-1506 |
|
| 1,2-Cyclohexanedicarboxylic anhydride, predominantly cis CAS:85-42-7 EC:201-604-9, 100 mg in 2 ml vial |
LK2-CRM4201-1507 |
|
| 1,3-Bis(2-isocyanato-2-propyl)benzene CAS:2778-42-9 EC:220-474-4, 250 mg in 1 ml ampoule |
LK2-CRM4201-1508 |
|
| 1,4-Diazabicyclo2.2.2octane CAS:280-57-9 EC:205-999-9, 100 mg in 2 ml vial |
LK2-CRM4201-1509 |
|
| 1,4-Phenylenediamine CAS:106-50-3 EC:203-404-7, 100 mg in 2 ml vial |
LK2-CRM4201-1510 |
|
| 1,5-Cyclooctadiene CAS:111-78-4 l EC:203-907-1, 100 mg in 2 ml vial |
LK2-CRM4201-1511 |
|
| 1.2-Naphthoquinone CAS:524-42-5 EC:208-360-2, 100 mg in 2 ml vial |
LK2-CRM4201-1512 |
|
| 1.4-Naphthoquinone CAS:130-15-4 l EC:204-977-6, 250mg in 2 ml vial |
LK2-CRM4201-1513 |
|
| 1-Acetyl-2-thiourea CAS:591-08-2 EC:209-699-9, 100 mg in 2 ml vial1-Ethyl-2-pyrrolidone CAS:2687-91-4 EC:220-250-6, 100 mg in 1 ml ampoule |
LK2-CRM4201-1514 |
|
| 1-Ethyl-2-pyrrolidone CAS:2687-91-4 EC:220-250-6, 100 mg in 1 ml ampoule |
LK2-CRM4201-1515 |
|
| 1H-Benzotriazole CAS:95-14-7 EC:202-394-1, 100 mg in 2 ml vial |
LK2-CRM4201-1516 |
|
| 1-Hexadecene CAS:629-73-2 EC:211-105-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1517 |
|
| 1-Naphthyl acetic acid CAS:86-87-3 EC:201-705-8, 500 mg in 2 ml vial |
LK2-CRM4201-1518 |
|
| 1-Nonadecene CAS:18435-45-5 EC:242-313-7, 100 mg in 2 ml vial |
LK2-CRM4201-1519 |
|
| 1-Propanethiol CAS:107-03-9 EC:203-455-5, 0,5 ml in 1 ml ampoule |
LK2-CRM4201-1520 |
|
| 2-(2H-Benzotriazol-2-yl)-4,6-di-tert-pentylphenol CAS:25973-55-1 EC:247-384-8, 100 mg in 2 ml vial |
LK2-CRM4201-1521 |
|
| 2-(Methylthio)benzothiazole CAS:615-22-5 EC:210-417-1, 100 mg in 2 ml vial |
LK2-CRM4201-1522 |
|
| 2,2,4-Trimethyl-1,3-pentanediol Diisobutyrate CAS:6846-50-0 EC:229-934-9, 1ml in 1 ml ampoule |
LK2-CRM4201-1523 |
|
| 1,1,3,3,5,5-Hexamethyltrisiloxane CAS:1189-93-1 EC:214-716-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1524 |
|
| 2,4,6-Tribromoanisole CAS:607-99-8, 100 mg in 2 ml vial |
LK2-CRM4201-1525 |
|
| 2,4,6-Trichloroanisole CAS:87-40-1 EC:201-743-5, 100 mg in 2 ml vial |
LK2-CRM4201-1526 |
|
| 2,4,7,9-Tetramethyl-5-decyne-4,7-diol CAS:126-86-3 EC:204-809-1, 100 mg in 2 ml vial |
LK2-CRM4201-1527 |
|
| 2,4-D CAS:94-75-7 EC:202-361-1, 100 mg in 2 ml vial |
LK2-CRM4201-1528 |
|
| 2,4-Diaminoanisole Sulfate Hydrate CAS:6219-67-6 EC:228-290-6, 100 mg in 2 ml vial |
LK2-CRM4201-1529 |
|
| 2,4-Dichlorobenzyl chloride CAS:94-99-5 EC:202-381-0, 100 mg in 1 ml ampoule |
LK2-CRM4201-1530 |
|
| 2,4-Dimethylaniline CAS:95-68-1 EC:202-440-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1531 |
|
| 2-Acetamidofluorene CAS:53-96-3 EC:200-188-6, 100 mg in 2 ml vial |
LK2-CRM4201-1532 |
|
| 2-Amino-1-naphthalenesulfonic acid CAS:81-16-3 EC:201-331-5, 100 mg in 2 ml vial |
LK2-CRM4201-1533 |
|
| 2-Amino-5-chloro-p-toluenesulfonic Acid CAS:88-53-9 EC:201-839-7, 100 mg in 2 ml vial |
LK2-CRM4201-1534 |
|
| 2-Aminoanthraquinone CAS:117-79-3 EC:204-208-4, 1000 mg in 4 ml vial |
LK2-CRM4201-1535 |
|
| 2-Butyloxyethyl acetate CAS:112-07-2 EC:203-933-3, 1ml in 1 ml ampoule |
LK2-CRM4201-1536 |
|
| 2-Chloro-1,1,2-trifluoroethyl difluoromethyl ether CAS:13838-16-9 EC:237-553-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1537 |
|
| 2-Chloroethyl Chloromethyl Ether CAS:1462-33-5, 100 mg in 2 ml vial |
LK2-CRM4201-1538 |
|
| 2-Ethylhexyl acrylate CAS:103-11-7 EC:203-080-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1539 |
|
| 2-Hydroxybenzothiazole CAS:934-34-9 EC:213-281-1, 100 mg in 2 ml vial |
LK2-CRM4201-1540 |
|
| 2-Hydroxyethyl methacrylate CAS:868-77-9 EC:212-782-2, 100 mg in 1 ml ampoule |
LK2-CRM4201-1541 |
|
| 2-Hydroxypropionitrile CAS:78-97-7 EC:201-163-2, 100 mg in 2 ml vial |
LK2-CRM4201-1542 |
|
| 2-Mercaptobenzothiazole CAS:149-30-4 EC:205-736-8, 1000 mg in 2 ml vial |
LK2-CRM4201-1543 |
|
| 2-Methoxy-4-nitroaniline CAS:97-52-9 EC:202-588-6, 100 mg in 2 ml vial |
LK2-CRM4201-1544 |
|
| 2-Methyl-1,3-dioxolane CAS:497-26-7 EC:207-841-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1545 |
|
| 2-Methylbenzothiazole CAS:120-75-2 EC:204-423-3, 100 mg in 2 ml vial |
LK2-CRM4201-1546 |
|
| 2-Methylstyrene (stabilized with TBC) CAS:611-15-4 EC:210-256-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1547 |
|
| 2-Nitrofluorene CAS:607-57-8 EC:210-138-5, 100 mg in 2 ml vial |
LK2-CRM4201-1548 |
|
| 2-Octyl-4-isothiazolin-3-one CAS:26530-20-1 EC:247-761-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1549 |
|
| 2-Picoline CAS:109-06-8 EC:203-643-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1550 |
|
| 2-Propanethiol CAS:75-33-2 EC:200-861-4, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1551 |
|
| 3-(Chloromethyl) pyridine hydrochloride CAS:6959-48-4 EC:230-150-4, 100 mg in 2 ml vial |
LK2-CRM4201-1552 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1553 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1554 |
|
| 3,3′-Dimethylbenzidine CAS:119-93-7 EC:204-358-0, 100 mg in 2 ml vial |
LK2-CRM4201-1555 |
|
| 3,6-Dichloropyridazine CAS:141-30-0 EC:205-478-6, 100 mg in 2 ml vial |
LK2-CRM4201-1556 |
|
| 3-Amino-4-methoxybenzanilide CAS:120-35-4 EC:204-388-4, 100 mg in 2 ml vial |
LK2-CRM4201-1557 |
|
| 3-Amino-4-methylbenzamide CAS:19406-86-1 EC:243-039-0, 100 mg in 2 ml vial |
LK2-CRM4201-1558 |
|
| 3-Amino-9-ethylcarbazole CAS:132-32-1 EC:205-057-7, 52 mg in 1 ml ampoule |
LK2-CRM4201-1559 |
|
| 3-Anisidine CAS:536-90-3 EC:208-651-4, 250 mg in 1 ml ampoule |
LK2-CRM4201-1560 |
|
| 3-Chloropropionitrile CAS:542-76-7 EC:208-827-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1561 |
|
| 3-Diethylaminopropionitrile CAS:5351-04-2 EC:226-323-9, 100 mg in 2 ml vial |
LK2-CRM4201-1562 |
|
| 3-Ethoxy-1-propanol CAS:111-35-3 EC:203-861-2, 100 mg in 2 ml vial |
LK2-CRM4201-1563 |
|
| 3-Methylbenzothiophene CAS:1455-18-1 EC:215-934-6, 100 mg in 2 ml vial |
LK2-CRM4201-1564 |
|
| 4,4′-Bis(dimethylamino)benzophenone CAS:90-94-8 EC:202-027-5, 100 mg in 2 ml vial |
LK2-CRM4201-1565 |
|
| 4,4′-DDT CAS:50-29-3 EC:200-024-3, 100 mg in 2 ml vial |
LK2-CRM4201-1566 |
|
| 4,4′-Methylene bis(N,N-dimethylaniline) CAS:101-61-1 EC:202-959-2, 250 mg in 4 ml vial |
LK2-CRM4201-1567 |
|
| 4,4′-Sulfonyldiphenol CAS:80-09-1 EC:201-250-5, 100 mg in 2 ml vial |
LK2-CRM4201-1568 |
|
| 4-Aminobenzamide CAS:2835-68-9 EC:220-612-3, 100 mg in 2 ml vial |
LK2-CRM4201-1569 |
|
| 4-Aminotoluene-3-sulfonic acid CAS:88-44-8 EC:201-831-3, 100 mg in 2 ml vial |
LK2-CRM4201-1570 |
|
| 4-Anisidine CAS:104-94-9 EC:203-254-2, 250 mg in 4 ml vial |
LK2-CRM4201-1571 |
|
| 4-Chloro-1,2-phenylenediamine CAS:95-83-0 EC:202-456-8, 100 mg in 2 ml vial |
LK2-CRM4201-1572 |
|
| 4-Chloro-1,3-phenylenediamine CAS:5131-60-2 EC:225-877-9, 100 mg in 2 ml vial |
LK2-CRM4201-1573 |
|
| 4-Cyano-1-cyclohexene CAS:100-45-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1574 |
|
| 4-Ethylguaiacol CAS:2785-89-9 EC:220-500-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1575 |
|
| 4-Methyl-2-nitroaniline CAS:89-62-3 EC:201-924-9, 250 mg in 4 ml vial |
LK2-CRM4201-1576 |
|
| 4-Methylcyclohexane-1,2-dicarboxylic Anhydride CAS:19438-60-9 EC:243-072-0, 100 mg in 2 ml vial |
LK2-CRM4201-1577 |
|
| 4-Methyldibenzothiophene CAS:7372-88-5, 100 mg in 2 ml vial |
LK2-CRM4201-1578 |
|
| 4-Nitroanisole CAS:100-17-4 EC:202-825-3, 100 mg in 2 ml vial |
LK2-CRM4201-1579 |
|
| 4-Nitro-o-phenylenediamine CAS:99-56-9 EC:202-766-3, 100 mg in 2 ml vial |
LK2-CRM4201-1580 |
|
| 1-Methyl-1H-benzotriazole CAS:13351-73-0 EC:236-401-4, 100 mg in 2 ml vial |
LK2-CRM4201-1502 |
|
| (+)-alpha-Pinene CAS:7785-70-8 EC:232-087-8, 100 mg in ml in 1 ml ampoule |
LK2-CRM4201-1503 |
|
| (R)-(+)-Limonene CAS:5989-27-5 EC:227-813-5, 100 mg in 1 ml ampoule |
LK2-CRM4201-1504 |
|
| 1-(2-Pyridyl)piperazine CAS:34803-66-2 EC:252-220-3, 100 mg in 1 ml ampoule |
LK2-CRM4201-1505 |
|
| 1,2-Benzisothiazol-3(2H)-one CAS:2634-33-5 EC:220-120-9, 100 mg in 2 ml vial |
LK2-CRM4201-1506 |
|
| 1,2-Cyclohexanedicarboxylic anhydride, predominantly cis CAS:85-42-7 EC:201-604-9, 100 mg in 2 ml vial |
LK2-CRM4201-1507 |
|
| 1,3-Bis(2-isocyanato-2-propyl)benzene CAS:2778-42-9 EC:220-474-4, 250 mg in 1 ml ampoule |
LK2-CRM4201-1508 |
|
| 1,4-Diazabicyclo2.2.2octane CAS:280-57-9 EC:205-999-9, 100 mg in 2 ml vial |
LK2-CRM4201-1509 |
|
| 1,4-Phenylenediamine CAS:106-50-3 EC:203-404-7, 100 mg in 2 ml vial |
LK2-CRM4201-1510 |
|
| 1,5-Cyclooctadiene CAS:111-78-4 l EC:203-907-1, 100 mg in 2 ml vial |
LK2-CRM4201-1511 |
|
| 1.2-Naphthoquinone CAS:524-42-5 EC:208-360-2, 100 mg in 2 ml vial |
LK2-CRM4201-1512 |
|
| 1.4-Naphthoquinone CAS:130-15-4 l EC:204-977-6, 250mg in 2 ml vial |
LK2-CRM4201-1513 |
|
| 1-Acetyl-2-thiourea CAS:591-08-2 EC:209-699-9, 100 mg in 2 ml vial1-Ethyl-2-pyrrolidone CAS:2687-91-4 EC:220-250-6, 100 mg in 1 ml ampoule |
LK2-CRM4201-1514 |
|
| 1-Ethyl-2-pyrrolidone CAS:2687-91-4 EC:220-250-6, 100 mg in 1 ml ampoule |
LK2-CRM4201-1515 |
|
| 1H-Benzotriazole CAS:95-14-7 EC:202-394-1, 100 mg in 2 ml vial |
LK2-CRM4201-1516 |
|
| 1-Hexadecene CAS:629-73-2 EC:211-105-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1517 |
|
| 1-Naphthyl acetic acid CAS:86-87-3 EC:201-705-8, 500 mg in 2 ml vial |
LK2-CRM4201-1518 |
|
| 1-Nonadecene CAS:18435-45-5 EC:242-313-7, 100 mg in 2 ml vial |
LK2-CRM4201-1519 |
|
| 1-Propanethiol CAS:107-03-9 EC:203-455-5, 0,5 ml in 1 ml ampoule |
LK2-CRM4201-1520 |
|
| 2-(2H-Benzotriazol-2-yl)-4,6-di-tert-pentylphenol CAS:25973-55-1 EC:247-384-8, 100 mg in 2 ml vial |
LK2-CRM4201-1521 |
|
| 2-(Methylthio)benzothiazole CAS:615-22-5 EC:210-417-1, 100 mg in 2 ml vial |
LK2-CRM4201-1522 |
|
| 2,2,4-Trimethyl-1,3-pentanediol Diisobutyrate CAS:6846-50-0 EC:229-934-9, 1ml in 1 ml ampoule |
LK2-CRM4201-1523 |
|
| 1,1,3,3,5,5-Hexamethyltrisiloxane CAS:1189-93-1 EC:214-716-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1524 |
|
| 2,4,6-Tribromoanisole CAS:607-99-8, 100 mg in 2 ml vial |
LK2-CRM4201-1525 |
|
| 2,4,6-Trichloroanisole CAS:87-40-1 EC:201-743-5, 100 mg in 2 ml vial |
LK2-CRM4201-1526 |
|
| 2,4,7,9-Tetramethyl-5-decyne-4,7-diol CAS:126-86-3 EC:204-809-1, 100 mg in 2 ml vial |
LK2-CRM4201-1527 |
|
| 2,4-D CAS:94-75-7 EC:202-361-1, 100 mg in 2 ml vial |
LK2-CRM4201-1528 |
|
| 2,4-Diaminoanisole Sulfate Hydrate CAS:6219-67-6 EC:228-290-6, 100 mg in 2 ml vial |
LK2-CRM4201-1529 |
|
| 2,4-Dichlorobenzyl chloride CAS:94-99-5 EC:202-381-0, 100 mg in 1 ml ampoule |
LK2-CRM4201-1530 |
|
| 2,4-Dimethylaniline CAS:95-68-1 EC:202-440-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1531 |
|
| 2-Acetamidofluorene CAS:53-96-3 EC:200-188-6, 100 mg in 2 ml vial |
LK2-CRM4201-1532 |
|
| 2-Amino-1-naphthalenesulfonic acid CAS:81-16-3 EC:201-331-5, 100 mg in 2 ml vial |
LK2-CRM4201-1533 |
|
| 2-Amino-5-chloro-p-toluenesulfonic Acid CAS:88-53-9 EC:201-839-7, 100 mg in 2 ml vial |
LK2-CRM4201-1534 |
|
| 2-Aminoanthraquinone CAS:117-79-3 EC:204-208-4, 1000 mg in 4 ml vial |
LK2-CRM4201-1535 |
|
| 2-Butyloxyethyl acetate CAS:112-07-2 EC:203-933-3, 1ml in 1 ml ampoule |
LK2-CRM4201-1536 |
|
| 2-Chloro-1,1,2-trifluoroethyl difluoromethyl ether CAS:13838-16-9 EC:237-553-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1537 |
|
| 2-Chloroethyl Chloromethyl Ether CAS:1462-33-5, 100 mg in 2 ml vial |
LK2-CRM4201-1538 |
|
| 2-Ethylhexyl acrylate CAS:103-11-7 EC:203-080-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1539 |
|
| 2-Hydroxybenzothiazole CAS:934-34-9 EC:213-281-1, 100 mg in 2 ml vial |
LK2-CRM4201-1540 |
|
| 2-Hydroxyethyl methacrylate CAS:868-77-9 EC:212-782-2, 100 mg in 1 ml ampoule |
LK2-CRM4201-1541 |
|
| 2-Hydroxypropionitrile CAS:78-97-7 EC:201-163-2, 100 mg in 2 ml vial |
LK2-CRM4201-1542 |
|
| 2-Mercaptobenzothiazole CAS:149-30-4 EC:205-736-8, 1000 mg in 2 ml vial |
LK2-CRM4201-1543 |
|
| 2-Methoxy-4-nitroaniline CAS:97-52-9 EC:202-588-6, 100 mg in 2 ml vial |
LK2-CRM4201-1544 |
|
| 2-Methyl-1,3-dioxolane CAS:497-26-7 EC:207-841-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1545 |
|
| 2-Methylbenzothiazole CAS:120-75-2 EC:204-423-3, 100 mg in 2 ml vial |
LK2-CRM4201-1546 |
|
| 2-Methylstyrene (stabilized with TBC) CAS:611-15-4 EC:210-256-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1547 |
|
| 2-Nitrofluorene CAS:607-57-8 EC:210-138-5, 100 mg in 2 ml vial |
LK2-CRM4201-1548 |
|
| 2-Octyl-4-isothiazolin-3-one CAS:26530-20-1 EC:247-761-7, 100 mg in 1 ml ampoule |
LK2-CRM4201-1549 |
|
| 2-Picoline CAS:109-06-8 EC:203-643-7, 1ml in 1 ml ampoule |
LK2-CRM4201-1550 |
|
| 2-Propanethiol CAS:75-33-2 EC:200-861-4, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1551 |
|
| 3-(Chloromethyl) pyridine hydrochloride CAS:6959-48-4 EC:230-150-4, 100 mg in 2 ml vial |
LK2-CRM4201-1552 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1553 |
|
| 3-(Triethoxysilyl)propyl isocyanate CAS:24801-88-5 EC:246-467-6, 100 mg in 2 ml vial |
LK2-CRM4201-1554 |
|
| 3,3′-Dimethylbenzidine CAS:119-93-7 EC:204-358-0, 100 mg in 2 ml vial |
LK2-CRM4201-1555 |
|
| 3,6-Dichloropyridazine CAS:141-30-0 EC:205-478-6, 100 mg in 2 ml vial |
LK2-CRM4201-1556 |
|
| 3-Amino-4-methoxybenzanilide CAS:120-35-4 EC:204-388-4, 100 mg in 2 ml vial |
LK2-CRM4201-1557 |
|
| 3-Amino-4-methylbenzamide CAS:19406-86-1 EC:243-039-0, 100 mg in 2 ml vial |
LK2-CRM4201-1558 |
|
| 3-Amino-9-ethylcarbazole CAS:132-32-1 EC:205-057-7, 52 mg in 1 ml ampoule |
LK2-CRM4201-1559 |
|
| 3-Anisidine CAS:536-90-3 EC:208-651-4, 250 mg in 1 ml ampoule |
LK2-CRM4201-1560 |
|
| 3-Chloropropionitrile CAS:542-76-7 EC:208-827-0, 0,5ml in 1 ml ampoule |
LK2-CRM4201-1561 |
|
| 3-Diethylaminopropionitrile CAS:5351-04-2 EC:226-323-9, 100 mg in 2 ml vial |
LK2-CRM4201-1562 |
|
| 3-Ethoxy-1-propanol CAS:111-35-3 EC:203-861-2, 100 mg in 2 ml vial |
LK2-CRM4201-1563 |
|
| 3-Methylbenzothiophene CAS:1455-18-1 EC:215-934-6, 100 mg in 2 ml vial |
LK2-CRM4201-1564 |
|
| 4,4′-Bis(dimethylamino)benzophenone CAS:90-94-8 EC:202-027-5, 100 mg in 2 ml vial |
LK2-CRM4201-1565 |
|
| 4,4′-DDT CAS:50-29-3 EC:200-024-3, 100 mg in 2 ml vial |
LK2-CRM4201-1566 |
|
| 4,4′-Methylene bis(N,N-dimethylaniline) CAS:101-61-1 EC:202-959-2, 250 mg in 4 ml vial |
LK2-CRM4201-1567 |
|
| 4,4′-Sulfonyldiphenol CAS:80-09-1 EC:201-250-5, 100 mg in 2 ml vial |
LK2-CRM4201-1568 |
|
| 4-Aminobenzamide CAS:2835-68-9 EC:220-612-3, 100 mg in 2 ml vial |
LK2-CRM4201-1569 |
|
| 4-Aminotoluene-3-sulfonic acid CAS:88-44-8 EC:201-831-3, 100 mg in 2 ml vial |
LK2-CRM4201-1570 |
|
| 4-Anisidine CAS:104-94-9 EC:203-254-2, 250 mg in 4 ml vial |
LK2-CRM4201-1571 |
|
| 4-Chloro-1,2-phenylenediamine CAS:95-83-0 EC:202-456-8, 100 mg in 2 ml vial |
LK2-CRM4201-1572 |
|
| 4-Chloro-1,3-phenylenediamine CAS:5131-60-2 EC:225-877-9, 100 mg in 2 ml vial |
LK2-CRM4201-1573 |
|
| 4-Cyano-1-cyclohexene CAS:100-45-8, 1ml in 1 ml ampoule |
LK2-CRM4201-1574 |
|
| 4-Ethylguaiacol CAS:2785-89-9 EC:220-500-4, 100 mg in 1 ml ampoule |
LK2-CRM4201-1575 |
|
| 4-Methyl-2-nitroaniline CAS:89-62-3 EC:201-924-9, 250 mg in 4 ml vial |
LK2-CRM4201-1576 |
|
| 4-Methylcyclohexane-1,2-dicarboxylic Anhydride CAS:19438-60-9 EC:243-072-0, 100 mg in 2 ml vial |
LK2-CRM4201-1577 |
|
| 4-Methyldibenzothiophene CAS:7372-88-5, 100 mg in 2 ml vial |
LK2-CRM4201-1578 |
|
| 4-Nitroanisole CAS:100-17-4 EC:202-825-3, 100 mg in 2 ml vial |
LK2-CRM4201-1579 |
|
| 4-Nitro-o-phenylenediamine CAS:99-56-9 EC:202-766-3, 100 mg in 2 ml vial |
LK2-CRM4201-1580 |
|
